When cardiomyopathy, cancer, and COVID-19 collide: A case report.
Breast J
; 27(4): 384-386, 2021 04.
Article
in English
| MEDLINE | ID: covidwho-1060031
ABSTRACT
Malignancy has historically prohibited solid organ transplant; however, patients with effectively treated, favorable-risk cancers should not necessarily be eliminated as transplant candidates. These cases require careful review by a multidisciplinary team. Here, we report the case of a woman with end-stage heart failure undergoing heart transplant evaluation during the COVID pandemic who was found to have early-stage, hormone receptor-positive breast cancer. Given her favorable cancer-related prognosis, a multidisciplinary committee recommended lumpectomy, accelerated partial breast irradiation, and adjuvant aromatase inhibitor therapy for definitive treatment to allow for consideration of orthotopic heart transplant.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
COVID-19
/
Heart Failure
/
Cardiomyopathies
Type of study:
Case report
/
Experimental Studies
/
Prognostic study
Topics:
Long Covid
Limits:
Female
/
Humans
/
Middle aged
Language:
English
Journal:
Breast J
Journal subject:
Neoplasms
Year:
2021
Document Type:
Article
Affiliation country:
Tbj.14182
Similar
MEDLINE
...
LILACS
LIS